During the past ten years, species-rich nations in the developing world hav
e sought to capitalize on their 'biological patrimony' through a variety of
business relationships with multinational corporations as a means of under
writing their conservation efforts. Initially lauded, these relationships h
ave generated more rhetoric than revenues to date. The ramifications of the
se results on bioprospecting are discussed along with the foreseeable chang
es in models of collaboration.